• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大鼠肾脏中钙离子通道阻滞剂维拉帕米与强心苷的相互作用]

[The interaction of the Ca2(+)-channel blocker verapamil with cardiac glycosides in the rat kidney].

作者信息

Kuz'min O B, Tarasov S V

出版信息

Eksp Klin Farmakol. 1992 Mar-Apr;55(2):30-2.

PMID:1422448
Abstract

Strophanthine (0.1 mg/kg, i. v.) and digoxin (0.1 mg/kg, i. v.) increase blood supply of the cortex and medullary layer of the kidneys of anesthetized rats and significantly raise excretion of water and sodium by the kidneys. Verapamil, a blocker of Ca(2+)-channels (0.25 mg/kg, i. v.) attenuates the increment of the blood flow in the internal zone of the cortex and external zone of the medullary layer but does not prevent the rise of diuresis and excretion of sodium with urine under the action of the above-indicated drugs. The conclusion is drawn that realization of the vasodilatory effect of cardiac glycosides in the kidneys is partially connected with a lowering of the content of Ca2+ in myofibrils whereas formation of their tubular effect does not depend on the changes in Ca2+ concentration in nephron cells.

摘要

毒毛花苷(0.1毫克/千克,静脉注射)和地高辛(0.1毫克/千克,静脉注射)可增加麻醉大鼠肾脏皮质和髓质层的血液供应,并显著提高肾脏对水和钠的排泄。钙通道阻滞剂维拉帕米(0.25毫克/千克,静脉注射)可减弱皮质内区和髓质层外区血流的增加,但在上述药物作用下并不能阻止利尿和尿钠排泄的增加。得出的结论是,强心苷在肾脏中的血管舒张作用的实现部分与肌原纤维中Ca2+含量的降低有关,而其肾小管效应的形成并不依赖于肾单位细胞中Ca2+浓度的变化。

相似文献

1
[The interaction of the Ca2(+)-channel blocker verapamil with cardiac glycosides in the rat kidney].[大鼠肾脏中钙离子通道阻滞剂维拉帕米与强心苷的相互作用]
Eksp Klin Farmakol. 1992 Mar-Apr;55(2):30-2.
2
[The interaction of the converting-enzyme inhibitor captopril with cardiac glycosides in the rat kidney].[大鼠肾脏中转化酶抑制剂卡托普利与强心苷的相互作用]
Eksp Klin Farmakol. 1995 Jan-Feb;58(1):37-40.
3
Renovascular responses to high and low perfusate calcium steady-state experiments in the isolated perfused rat kidney with baseline vascular tone.在具有基础血管张力的离体灌注大鼠肾脏中,对高钙和低钙灌注液稳态实验的肾血管反应。
J Surg Res. 1996 Feb 15;61(1):51-7. doi: 10.1006/jsre.1996.0080.
4
[The influence of inhibitors of kinin and prostaglandin formation on the vascular and tubular effects of osmotic diuretics in the kidney].[激肽和前列腺素生成抑制剂对肾脏中渗透性利尿剂的血管和肾小管效应的影响]
Farmakol Toksikol. 1990 Jan-Feb;53(1):46-8.
5
[Role of kidney prostaglandins, kinins and dopamine receptors in the natriuretic effect of ethacrynic acid].[肾脏前列腺素、激肽及多巴胺受体在依他尼酸利钠作用中的作用]
Farmakol Toksikol. 1987 Sep-Oct;50(5):39-42.
6
[Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].[呋塞米与肾脏前列腺素及激肽释放酶-激肽系统的相互作用]
Farmakol Toksikol. 1986 Mar-Apr;49(2):21-4.
7
[Effect of verapamil (isoptin) on kidney function].[维拉帕米(异搏定)对肾功能的影响]
Farmakol Toksikol. 1980 Jan-Feb;43(1):74-7.
8
[The role of the natriuretic hormone in the action of nifedipine and verapamil on the kidneys].[利钠激素在硝苯地平与维拉帕米对肾脏作用中的角色]
Eksp Klin Farmakol. 1997 Jan-Feb;60(1):40-1.
9
Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.
Res Commun Chem Pathol Pharmacol. 1984 Jul;45(1):3-18.
10
Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.新型二氢吡啶类钙通道阻滞剂CS-905对大鼠动脉血压、肾脏排泄功能及肾髓质血流量的影响。
Am J Hypertens. 1994 Jul;7(7 Pt 1):637-46.